Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Archer

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
Menopause (New York, N.Y.)|January 28, 2012
Transdermal estradiol gel for the treatment of symptomatic postmenopausal womenDavid F Archer, James H Pickar, Dipali C MacAllister, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 19, 2021
The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual CyclesEsra Demirel, Reem Sabouni, Neelima Chandra, et al.
Menopause (New York, N.Y.)|September 21, 2016
Prescribing of FDA-approved and compounded hormone therapy differs by specialtyGinger D Constantine, David F Archer, Shelli Graham, et al.
Contraception|January 15, 2013
TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studiesTerry A Jacot, Irina Zalenskaya, Christine Mauck, et al.
Menopause (New York, N.Y.)|August 15, 2013
Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third National Health and Nutrition Examination SurveyHind A Beydoun, Rawan el-Amin, Malikah McNeal, et al.
Menopause (New York, N.Y.)|August 22, 2013
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptomsGabriele Sutter, Thomas Schmelter, Kerstin Gude, et al.
Obstetrics and Gynecology|November 4, 2008
Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tabletJames Simon, Lila Nachtigall, Robert Gut, et al.
Fertility and Sterility|July 29, 2009
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal womenDavid F Archer, Vivian Lewis, Bruce R Carr, et al.
Contraception|October 6, 2012
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrelMarie Foegh, David F Archer, Frank Z Stanczyk, et al.
American Journal of Obstetrics and Gynecology|December 27, 2008
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopauseDavid F Archer, Larry Seidman, Ginger D Constantine, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
Menopause (New York, N.Y.)|January 28, 2012
Transdermal estradiol gel for the treatment of symptomatic postmenopausal womenDavid F Archer, James H Pickar, Dipali C MacAllister, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 19, 2021
The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual CyclesEsra Demirel, Reem Sabouni, Neelima Chandra, et al.
Menopause (New York, N.Y.)|September 21, 2016
Prescribing of FDA-approved and compounded hormone therapy differs by specialtyGinger D Constantine, David F Archer, Shelli Graham, et al.
Contraception|January 15, 2013
TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studiesTerry A Jacot, Irina Zalenskaya, Christine Mauck, et al.
Menopause (New York, N.Y.)|August 15, 2013
Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third National Health and Nutrition Examination SurveyHind A Beydoun, Rawan el-Amin, Malikah McNeal, et al.
Menopause (New York, N.Y.)|August 22, 2013
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptomsGabriele Sutter, Thomas Schmelter, Kerstin Gude, et al.
Obstetrics and Gynecology|November 4, 2008
Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tabletJames Simon, Lila Nachtigall, Robert Gut, et al.
Fertility and Sterility|July 29, 2009
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal womenDavid F Archer, Vivian Lewis, Bruce R Carr, et al.
Contraception|October 6, 2012
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrelMarie Foegh, David F Archer, Frank Z Stanczyk, et al.
American Journal of Obstetrics and Gynecology|December 27, 2008
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopauseDavid F Archer, Larry Seidman, Ginger D Constantine, et al.
Pageof 20